Evidence map›Paper›PMID 26918037›Full record

ArticleJournal of Cancer2016

Molecular Mechanism of Cinnamomum verum Component Cuminaldehyde Inhibits Cell Growth and Induces Cell Death in Human Lung Squamous Cell Carcinoma NCI-H520 Cells In Vitro and In Vivo.

Shu-Mei Yang, Kuen-Daw Tsai, Ho-Yiu Wong, Yi-Heng Liu, Ta-Wei Chen, Jonathan Cherng, Kwang-Ching Hsu, Yao-Uh Ang, Jaw-Ming Cherng

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Synergistic potential and apoptosis induction ofCurrent medical mycology · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Shu-Mei Yang1. Department of Internal Medicine, China Medical University Beigang Hospital, Yunlin, Taiwan ROC; 2. School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan ROC.
Kuen-Daw Tsai1. Department of Internal Medicine, China Medical University Beigang Hospital, Yunlin, Taiwan ROC; 2. School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan ROC; 3. Institute of Molecular Biology, National Chung Cheng University, Chiayi, Taiwan ROC.
Ho-Yiu Wong1. Department of Internal Medicine, China Medical University Beigang Hospital, Yunlin, Taiwan ROC.
Yi-Heng Liu1. Department of Internal Medicine, China Medical University Beigang Hospital, Yunlin, Taiwan ROC.
Ta-Wei Chen1. Department of Internal Medicine, China Medical University Beigang Hospital, Yunlin, Taiwan ROC.
Jonathan Cherng4. Faculty of Medicine, Medical University of Lublin, Lublin, Poland.
Kwang-Ching Hsu5. Department of Internal Medicine, Saint Mary's Hospital Luodong, Yilan, Taiwan ROC.
Yao-Uh Ang5. Department of Internal Medicine, Saint Mary's Hospital Luodong, Yilan, Taiwan ROC.
Jaw-Ming Cherng5. Department of Internal Medicine, Saint Mary's Hospital Luodong, Yilan, Taiwan ROC.
China Medical University Beigang Hospital · TWChina Medical University · TWSaint Mary's Hospital Luodong · TWMedical University of Lublin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cinnamomum verum is used to make the spice cinnamon and has been used as a traditional Chinese herbal medicine. We evaluated the effects and the molecular mechanisms of cuminaldehyde (CuA), a constituent of the bark of Cinnamomum verum, on human lung squamous cell carcinoma NCI-H520 cells. Specifically, cell viability was evaluated by colorimetric assay; cytotoxicity by LDH release; apoptosis was determined by Western blotting, and morphological analysis with, acridine orange and neutral red stainings and comet assay; topoisomerase I activity was assessed using assay based upon DNA relaxation and topoisomerase II by DNA relaxation plus decatentation of kinetoplast DNA; lysosomal vacuolation and volume of acidic compartments (VAC) were evaluated with neutral red staining. The results show that CuA suppressed proliferation and induced apoptosis as indicated by an up-regulation of pro-apoptotic bax and bak genes and a down-regulation of anti-apoptotic bcl-2 and bcl-XL genes, mitochondrial membrane potential loss, cytochrome c release, activation of caspase 3 and 9, and morphological characteristics of apoptosis, including blebbing of the plasma membrane, nuclear condensation, fragmentation, apoptotic body formation, and comet with elevated tail intensity and moment. In addition, CuA also induced lysosomal vacuolation with increased VAC, cytotoxicity, as well as suppressions of both topoisomerase I and II activities in a dose-dependent manner. Further study revealed the growth-inhibitory effect of CuA was also evident in a nude mice model. Taken together, the data suggest that the growth-inhibitory effect of CuA against NCI-H520 cells is accompanied by downregulations of proliferative control involving apoptosis and both topoisomerase I and II activities, and upregulation of lysosomal with increased VAC and cytotoxicity. Similar effects were found in other cell lines, including human lung adenocarcinoma A549 cells and colorectal adenocarcinoma COLO 205 (results not shown). Our data suggest that CuA could be a potential agent for anticancer therapy.

Indexed as

anticancerCuminaldehydecytotoxicitylysosomal vacuolationNCI-H520 cellstopoisomerase Itopoisomerase IIxenograft

Identifiers

PMID26918037
PMCPMC4747878
OpenAlexW2405713711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.